ROYAL BANK OF CANADA - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M601. A total of 38 filers reported holding ACORDA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$0329
+1.9%
0.00%
Q4 2022$0323
-4.2%
0.00%
Q3 2022$0337
+15.0%
0.00%
Q2 2022$0293
-12.8%
0.00%
Q1 2022$0
-100.0%
336
-62.5%
0.00%
Q4 2021$3,000
+200.0%
895
+256.6%
0.00%
Q3 2021$1,000
-50.0%
251
-43.6%
0.00%
Q2 2021$2,000
-60.0%
445
-58.6%
0.00%
Q1 2021$5,0001,0760.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DAVIDSON KEMPNER PARTNERS 1,803,070$1,009,7190.02%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 1,803,070$1,009,7190.02%
Saltoro Capital, LP 51,391$23,8970.02%
ACADIAN ASSET MANAGEMENT LLC 682,638$3980.00%
TWO SIGMA SECURITIES, LLC 141,152$82,7150.00%
Renaissance Technologies 885,292$5190.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 76,706$44,9500.00%
SIMON QUICK ADVISORS, LLC 14,370$8,4210.00%
FIRST MANHATTAN CO. LLC. 50$290.00%
Russell Investments Group, Ltd. 6,000$3,5160.00%
View complete list of ACORDA THERAPEUTICS INC shareholders